Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line

• Prif Awduron: Maria Carolina Ximenes de Godoy (Awdur), Juliana Alves Macedo (Awdur), Alessandra Gambero (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2024-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Therapeutically targeting senescent cells seems to be an interesting perspective in treating chronic lung diseases, which are often associated with human aging. The combination of the drug dasatinib and the polyphenol quercetin is used in clinical trials as a senolytic, and the first results point t...